{"id":67982,"date":"2026-10-24T18:51:49","date_gmt":"2026-10-24T13:21:49","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=67982"},"modified":"2026-10-24T18:51:56","modified_gmt":"2026-10-24T13:21:56","slug":"new-series-of-interactive-cardiology-mcqs-12","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/","title":{"rendered":"New Series of Interactive Cardiology MCQs 12"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<!-- Cardiology MCQs Part 12 (Full 25 Questions) - WordPress Safe Custom HTML Block -->\n<script src=\"https:\/\/cdn.tailwindcss.com?plugins=forms,typography,aspect-ratio\"><\/script>\n<script>\n  tailwind.config = {\n    corePlugins: {\n      preflight: false,\n    }\n  }\n<\/script>\n\n<div id=\"mcq12-quiz-wrapper\" class=\"font-sans bg-slate-950 text-slate-100 p-4 md:p-8 rounded-3xl max-w-4xl mx-auto shadow-2xl relative overflow-hidden my-8 border border-solid border-purple-500\/20\" style=\"box-sizing: border-box;\">\n  \n  <!-- Background Accents -->\n  <div class=\"absolute top-0 left-0 w-full h-full pointer-events-none opacity-10 bg-[radial-gradient(ellipse_at_center,_var(--tw-gradient-stops))] from-blue-500 via-indigo-900 to-slate-950\"><\/div>\n  \n  <!-- Header Banner -->\n  <div class=\"relative text-center pb-6 border-b border-solid border-purple-500\/25 mb-8\">\n    <div class=\"inline-block bg-gradient-to-r from-red-600 via-pink-600 to-purple-600 text-white font-black text-xs md:text-sm px-4 py-1.5 rounded-full uppercase tracking-wider shadow-lg mb-3 animate-pulse\">\n      \u2764\ufe0f Advanced Cardiology Series &#8211; Part 12\n    <\/div>\n    <h1 class=\"text-3xl md:text-5xl font-extrabold tracking-tight text-transparent bg-clip-text bg-gradient-to-r from-cyan-300 via-blue-400 to-indigo-400 m-0\">\n      Interactive Cardiology MCQs #12\n    <\/h1>\n    <p class=\"text-sm md:text-lg text-slate-300 mt-2 max-w-2xl mx-auto font-medium\">\n      Post-Graduate Level Clinical &#038; Hemodynamic Masterclass\n    <\/p>\n  <\/div>\n\n  <!-- Real-Time Floating Scoreboard -->\n  <div class=\"sticky top-4 z-40 bg-slate-900\/90 backdrop-blur-md border-2 border-solid border-blue-500\/40 rounded-2xl p-4 mb-8 shadow-xl flex flex-wrap items-center justify-between gap-4\">\n    <div class=\"flex items-center gap-3\">\n      <div class=\"text-3xl\">\ud83c\udfc6<\/div>\n      <div>\n        <div class=\"text-[10px] uppercase font-extrabold tracking-widest text-blue-300\">Live Scoreboard<\/div>\n        <div class=\"text-lg md:text-2xl font-black text-cyan-300 flex items-center gap-1\">\n          <span id=\"mcq12-correct-count\">0<\/span><span class=\"text-slate-500 text-sm md:text-lg\">\/ 25 Correct<\/span>\n        <\/div>\n      <\/div>\n    <\/div>\n    <div class=\"flex items-center gap-2 bg-slate-950\/80 px-4 py-2 rounded-xl border border-solid border-slate-800\">\n      <span class=\"text-xs font-bold text-slate-400 uppercase tracking-wider\">Progress:<\/span>\n      <div class=\"w-24 md:w-36 bg-slate-800 h-3 rounded-full overflow-hidden\">\n        <div id=\"mcq12-progress-bar\" class=\"bg-gradient-to-r from-blue-500 to-cyan-400 h-full w-0 transition-all duration-300 rounded-full\"><\/div>\n      <\/div>\n      <span class=\"text-xs font-bold text-cyan-300\"><span id=\"mcq12-answered-count\">0<\/span>\/25<\/span>\n    <\/div>\n  <\/div>\n\n  <!-- Quiz Questions Container -->\n  <div class=\"space-y-8 relative\">\n\n    <!-- Q1 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q1<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Which invasive intracoronary imaging modality provides the highest spatial resolution (10-20 micrometers) and is considered the gold standard for identifying thin-cap fibroatheromas, macrophage accumulation, and assessing stent strut endothelialization?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"IVUS uses sound waves, providing deep tissue penetration but lower spatial resolution (approx 100 micrometers), making it inferior for viewing thin fibrous caps.\">A. Intravascular Ultrasound (IVUS)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Optical Coherence Tomography (OCT) utilizes near-infrared light, offering superior spatial resolution (10-20 micrometers) ideal for detailed evaluation of plaque vulnerability, stent malapposition, and strut coverage.\">B. Optical Coherence Tomography (OCT)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"FFR assesses physiological flow limitation, not high-resolution plaque morphology.\">C. Fractional Flow Reserve (FFR)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"NIRS is excellent for identifying lipid core plaques but lacks the high spatial resolution of OCT for assessing stent struts or fibrous cap thickness.\">D. Near-Infrared Spectroscopy (NIRS)<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q2 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q2<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In cardio-oncology, which echocardiographic parameter is the most sensitive early predictor of anthracycline-induced cardiotoxicity prior to a decline in left ventricular ejection fraction (LVEF)?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Mitral E\/A ratio evaluates diastolic function but is not the most sensitive or specific early predictor of subclinical anthracycline toxicity.\">A. Reversal of the mitral E\/A ratio<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"A relative percentage reduction of &gt;15% in Global Longitudinal Strain (GLS) by speckle-tracking echocardiography is the most robust early marker of subclinical myocardial injury during chemotherapy, preceding LVEF decline.\">B. A relative reduction in Global Longitudinal Strain (GLS) of &gt; 15%<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Increased LV end-diastolic volume is a late sign of adverse remodeling.\">C. An increase in left ventricular end-diastolic volume index &gt; 10%<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Decreased TAPSE evaluates right ventricular function and is not the primary sentinel marker for anthracycline toxicity.\">D. A decrease in TAPSE to &lt; 16 mm<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q3 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q3<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          According to current guidelines, what is the primary indication for percutaneous left atrial appendage (LAA) closure (e.g., Watchman device) in a patient with atrial fibrillation?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"DOACs are first-line for uncomplicated non-valvular AF; procedural closure is not a first-line convenience alternative.\">A. First-line therapy for all patients with non-valvular AF to avoid the inconvenience of daily medications<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"LAA closure is indicated for patients with non-valvular atrial fibrillation who have a high stroke risk (high CHA2DS2-VASc) but possess an appropriate rationale to seek a non-pharmacologic alternative, most notably a high risk of bleeding or contraindication to long-term oral anticoagulation.\">B. Patients with non-valvular AF and high stroke risk who have a strong clinical rationale to avoid long-term oral anticoagulants (e.g., high bleeding risk)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"LAA closure devices are strictly for non-valvular AF. Rheumatic mitral stenosis requires systemic anticoagulation.\">C. Patients with valvular AF secondary to severe rheumatic mitral stenosis<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Atrial flutter with a CHADS2 score of 0 does not require systemic anticoagulation or LAA closure.\">D. Patients with typical atrial flutter and a CHA2DS2-VASc score of 0<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q4 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q4<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Which of the following is a classic and severe late complication of the Fontan palliation for single-ventricle congenital heart disease, characterized by chronic severe diarrhea, hypoproteinemia, and immunodeficiency?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Protein-losing enteropathy (PLE) is a severe, life-threatening late complication of the Fontan circulation, driven by chronically elevated central venous pressures leading to intestinal lymphangiectasia and profound enteric protein loss.\">A. Protein-losing enteropathy (PLE)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Cyanotic nephropathy occurs in unrepaired cyanotic lesions, not typically as the defining diarrheal\/hypoproteinemic complication of a Fontan.\">B. Cyanotic nephropathy<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Eisenmenger syndrome is a consequence of unrepaired left-to-right shunts, whereas a Fontan creates passive pulmonary blood flow.\">C. Eisenmenger syndrome<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Aortopulmonary collateral formation occurs in tetralogy of Fallot with pulmonary atresia, not as the primary cause of hypoproteinemia in Fontan patients.\">D. Major aortopulmonary collateral arteries (MAPCAs)<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q5 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q5<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          What is the exact pharmacological mechanism of action of the novel lipid-lowering agent inclisiran?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Evolocumab and alirocumab are monoclonal antibodies that bind directly to circulating PCSK9 protein.\">A. It is a monoclonal antibody that directly binds and neutralizes circulating PCSK9 protein.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Ezetimibe inhibits the NPC1L1 transporter in the gut.\">B. It inhibits the NPC1L1 transporter in the intestinal brush border.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Inclisiran is a small interfering RNA (siRNA) that utilizes RNA interference to inhibit the intracellular translation of PCSK9 mRNA in hepatocytes, drastically lowering PCSK9 production.\">C. It is a small interfering RNA (siRNA) that halts intracellular translation of PCSK9 mRNA in the liver.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Bempedoic acid inhibits ATP citrate lyase upstream of HMG-CoA reductase.\">D. It inhibits ATP citrate lyase, preventing early cholesterol biosynthesis.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q6 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q6<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Which of the following clinical scenarios represents an absolute contraindication to the implantation of a subcutaneous implantable cardioverter-defibrillator (S-ICD)?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"End-stage renal disease with lack of venous access is actually a primary *indication* for an S-ICD because it avoids intravascular leads.\">A. End-stage renal disease with bilateral central venous occlusion<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"An S-ICD cannot deliver anti-tachycardia pacing (ATP) for monomorphic VT, nor can it provide reliable bradycardia pacing. Patients requiring ATP, bradycardia pacing, or CRT are contraindicated for S-ICD.\">B. A history of recurrent slow monomorphic ventricular tachycardia requiring anti-tachycardia pacing (ATP)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Brugada syndrome patients are often excellent candidates for S-ICD due to their young age and risk of VF, provided they pass S-ICD ECG screening.\">C. Documented Brugada syndrome with prior cardiac arrest<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Young age is a common reason to choose S-ICD to avoid lifetime intravascular lead complications.\">D. Age under 40 years<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q7 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q7<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient has an LVEF of 30%, aortic valve area of 0.8 cm&sup2;, and a mean gradient of 25 mmHg. Which diagnostic test is most appropriate to differentiate true severe low-flow, low-gradient aortic stenosis from pseudosevere aortic stenosis?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Cardiac MRI is excellent for volumes and fibrosis, but cannot dynamically test valve compliance under increased flow.\">A. Resting cardiac magnetic resonance imaging (CMR)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Treadmill exercise is contraindicated in symptomatic severe AS and does not precisely assess contractile reserve.\">B. Treadmill exercise stress echocardiography<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Low-dose dobutamine stress echocardiography evaluates flow reserve. If stroke volume increases and the gradient rises &gt;40 mmHg while AVA stays &lt;1.0 cm&sup2;, it is true severe AS. If AVA increases &gt;1.0 cm&sup2;, it is pseudosevere AS.\">C. Low-dose dobutamine stress echocardiography<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Right heart catheterization assesses pulmonary pressures, not aortic valve opening mechanics.\">D. Right heart catheterization with thermodilution cardiac output<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q8 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q8<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          According to the Fourth Universal Definition of Myocardial Infarction, which of the following is a mandatory criterion for the diagnosis of MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries)?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"MINOCA diagnosis requires meeting acute MI criteria (cTn rise\/fall with ischemia), non-obstructive coronaries (all &lt; 50% stenosis) on angiography, and no specific alternative diagnosis (e.g., myocarditis, PE) clinically apparent at presentation.\">A. Meeting acute MI criteria, angiographic stenosis &lt; 50% in all epicardial vessels, and no clinically apparent specific alternative diagnosis<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Myocarditis is an alternative diagnosis that excludes the diagnosis of MINOCA.\">B. Confirmation of acute viral myocarditis on cardiac MRI<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Presence of a 60% stenosis is obstructive CAD, which rules out MINOCA.\">C. Presence of at least one epicardial stenosis between 50% and 70%<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Takotsubo syndrome is categorized separately from true ischemic MINOCA in updated working group definitions.\">D. Confirmation of typical apical ballooning syndrome (Takotsubo)<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q9 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q9<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Based on the results of the LoDoCo2 and COLCOT trials, low-dose colchicine has been integrated into guidelines for which specific indication?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Colchicine reduces pericarditis recurrence, but LoDoCo2\/COLCOT specifically investigated coronary disease outcomes.\">A. Prevention of recurrent acute pericarditis post-cardiac surgery only<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"LoDoCo2 (chronic coronary disease) and COLCOT (recent MI) demonstrated that low-dose colchicine significantly reduces cardiovascular events via targeted anti-inflammatory effects in atherothrombosis.\">B. Secondary prevention to reduce major adverse cardiovascular events in patients with chronic coronary disease or recent myocardial infarction<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Colchicine has no role in heart rate control for AF.\">C. Maintenance of sinus rhythm in paroxysmal atrial fibrillation<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Colchicine does not dissolve acute left ventricular thrombi; anticoagulation is required.\">D. Dissolution of acute left ventricular mural thrombus<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q10 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q10<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A 35-year-old male with a history of unexplained syncope has a non-diagnostic baseline ECG. Which pharmacological agent is administered during a provocation challenge to unmask the Type 1 ECG pattern of Brugada syndrome?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Isoproterenol (a beta agonist) is used to suppress VT in Brugada syndrome or provoke arrhythmias in congenital long QT, not unmask Brugada.\">A. Isoproterenol<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Adenosine causes transient AV block and is used for SVT termination.\">B. Adenosine<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Sodium channel blockers like Ajmaline, Flecainide, or Procainamide are used during provocation testing to unmask the classic coved ST-segment elevation (Type 1 pattern) in suspected Brugada syndrome.\">C. Ajmaline or Flecainide<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Epinephrine is used in CPVT or LQT provocation testing.\">D. Epinephrine<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q11 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q11<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In hypertrophic obstructive cardiomyopathy (HOCM), systolic anterior motion (SAM) of the mitral valve leads to dynamic left ventricular outflow tract (LVOT) obstruction. What is the primary hemodynamic consequence of SAM on the mitral valve itself?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"As the anterior mitral leaflet is dragged into the LVOT during systole, coaptation fails, resulting in an eccentric, posteriorly directed jet of mitral regurgitation.\">A. Eccentric, posteriorly directed mitral regurgitation<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"SAM causes mitral regurgitation, not functional mitral stenosis.\">B. Functional diastolic mitral stenosis<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Central mitral regurgitation is typical of dilated cardiomyopathy (annular dilation), whereas SAM produces an eccentric jet.\">C. Central, symmetric severe mitral regurgitation<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Flail leaflets involve torn chords; SAM is a dynamic fluid mechanics issue.\">D. Flail anterior mitral leaflet<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q12 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q12<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          An adult patient presents with upper extremity hypertension and diminished femoral pulses. A chest radiograph reveals bilateral inferior rib notching. What is the diagnosis and the cause of the radiographic finding?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Takayasu arteritis causes upper extremity pulselessness, not classically rib notching.\">A. Takayasu arteritis with subclavian steal<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Marfan syndrome causes aortic root dilation, not rib notching.\">B. Marfan syndrome with descending aortic dissection<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Coarctation of the aorta forces blood to bypass the stricture through enlarged, tortuous intercostal collateral arteries, which erode the inferior margins of the ribs (Roesler sign).\">C. Coarctation of the aorta causing enlargement of intercostal collateral arteries<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Tetralogy of Fallot causes cyanosis and a boot-shaped heart, not rib notching.\">D. Tetralogy of Fallot with pulmonary atresia<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q13 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q13<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          When differentiating constrictive pericarditis from restrictive cardiomyopathy via tissue Doppler echocardiography, which specific finding strongly favors constrictive pericarditis?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Annulus reversus occurs in constriction because the tethered lateral wall cannot expand, making the medial septal e' velocity paradoxically higher (medial e' &gt; lateral e') than the lateral velocity.\">A. Annulus reversus (medial mitral e&#8217; velocity &gt; lateral e&#8217; velocity)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Restrictive cardiomyopathy features severely depressed e' velocities globally (e.g., &lt; 8 cm\/s), whereas constriction maintains preserved or heightened septal e' velocities.\">B. Global severe depression of both medial and lateral e&#8217; velocities (&lt; 5 cm\/s)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Lack of respiratory variation in mitral inflow velocity is a hallmark of restrictive cardiomyopathy. Constriction shows &gt;25% variation.\">C. Lack of respiratory variation in mitral E-wave velocity<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Biatrial enlargement is severe in restrictive cardiomyopathy but only mild\/moderate in constriction.\">D. Massive biatrial enlargement with normal ventricular size<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q14 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q14<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A nuclear technetium-99m pyrophosphate (Tc-99m PYP) scintigraphy scan demonstrates intense myocardial tracer uptake (Grade 3, greater than bone uptake). In the absence of a monoclonal protein, this finding is highly specific for which condition?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"AL (light chain) amyloidosis requires hematologic workup and does not typically show intense Grade 2\/3 uptake on PYP scanning.\">A. AL (Light Chain) Cardiac Amyloidosis<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Tc-99m PYP (or DPD\/HMDP) scanning with Grade 2 or 3 uptake, combined with negative serum\/urine immunofixation, has nearly 100% specificity for Transthyretin (ATTR) cardiac amyloidosis.\">B. Transthyretin (ATTR) Cardiac Amyloidosis<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Cardiac sarcoidosis is imaged via 18F-FDG PET, not Tc-99m PYP.\">C. Cardiac Sarcoidosis<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Fabry disease is a lysosomal storage disorder diagnosed by alpha-galactosidase A levels, not bone tracer avidity.\">D. Fabry Disease<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q15 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q15<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          What is a primary guideline indication for the implantation of a single-chamber percutaneous leadless pacemaker (e.g., Micra) over a traditional transvenous pacemaker?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Complete heart block in young patients with normal sinus rhythm requires dual-chamber AV synchrony, making standard single-chamber VVI leadless pacing suboptimal.\">A. Complete heart block in a 30-year-old athlete requiring AV synchronous pacing<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Patients with permanent atrial fibrillation (where atrial pacing is useless) and symptomatic bradycardia, or those with obstructed superior venous access or high infection risk, are prime candidates for right ventricular leadless VVI pacemakers.\">B. Permanent atrial fibrillation with symptomatic bradycardia or patients with absent upper extremity venous access<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Heart failure requiring CRT requires left ventricular pacing, which standard single right-sided leadless devices cannot achieve.\">C. Heart failure with reduced ejection fraction requiring cardiac resynchronization therapy (CRT)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Sinoatrial node dysfunction requires an atrial pacing capability (AAI\/DDD) to prevent pacemaker syndrome.\">D. Severe sinoatrial node dysfunction (sick sinus syndrome) with intact AV conduction<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q16 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q16<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In contemporary physiological lesion assessment, how does the instantaneous wave-free ratio (iFR) differ methodologically from Fractional Flow Reserve (FFR)?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"iFR isolates the specific 'wave-free period' during diastole when microvascular resistance is naturally constant and minimized, negating the need for pharmacological vasodilators like adenosine.\">A. iFR is measured only during a specific diastolic wave-free period and does not require the administration of hyperemic agents (adenosine).<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"iFR evaluates intracoronary pressures using a pressure wire, not ultrasound.\">B. iFR utilizes intravascular ultrasound cross-sectional area rather than pressure gradients.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"FFR requires adenosine; iFR was developed specifically to avoid it.\">C. iFR requires double the dose of intracoronary adenosine compared to FFR.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Both iFR and FFR assess epicardial stenosis severity, not primarily microvascular resistance (which is measured by IMR).\">D. iFR exclusively evaluates the microvascular compartment while ignoring epicardial stenosis.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q17 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q17<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          What is the standard cornerstone maintenance immunosuppression regimen prescribed immediately following orthotopic heart transplantation?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Cyclophosphamide and rituximab are used in vasculitis and oncology, not routine solid organ transplant maintenance.\">A. Cyclophosphamide, rituximab, and high-dose aspirin<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Standard triple therapy consists of a calcineurin inhibitor (tacrolimus or cyclosporine), an antimetabolite\/antiproliferative agent (mycophenolate mofetil), and corticosteroids.\">B. Calcineurin inhibitor (e.g., tacrolimus), an antiproliferative agent (e.g., mycophenolate mofetil), and corticosteroids<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"mTOR inhibitors (sirolimus\/everolimus) are generally introduced later to spare renal function or limit cardiac allograft vasculopathy, replacing the CNI or antimetabolite.\">C. Sirolimus monotherapy<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Azathioprine is an older antimetabolite, but NSAIDs are avoided due to renal toxicity and blunting of rejection signs.\">D. Azathioprine and non-steroidal anti-inflammatory drugs (NSAIDs)<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q18 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q18<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          According to the World Health Organization (WHO) maternal cardiovascular risk classification, pregnancy is absolutely contraindicated (Class IV risk) in women with which condition?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Eisenmenger syndrome, severe symptomatic aortic stenosis, severe pulmonary arterial hypertension, and LVEF &lt; 30% are WHO Class IV due to maternal mortality risks exceeding 20-50%.\">A. Eisenmenger syndrome \/ Pulmonary arterial hypertension<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Repaired tetralogy of Fallot without severe RV dysfunction is generally WHO Class II.\">B. Surgically repaired Tetralogy of Fallot with mild pulmonary regurgitation<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"MVP with mild MR is WHO Class I (very low risk).\">C. Mitral valve prolapse with mild regurgitation<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Small, hemodynamically insignificant ASDs are WHO Class I or II.\">D. Unrepaired small ostium secundum atrial septal defect<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q19 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q19<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          What is the novel mechanism of action of sotatercept, a recently approved disease-modifying therapy for Pulmonary Arterial Hypertension (PAH)?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes the mechanism of continuous intravenous epoprostenol.\">A. It is a synthetic prostacyclin analog promoting direct vasodilation.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Sotatercept is an activin signaling inhibitor (a fusion protein) that binds TGF-beta superfamily ligands, restoring the balance between pro-proliferative (Activin\/TGF-b) and anti-proliferative (BMPR2) pathways to reverse pulmonary vascular remodeling.\">B. It acts as an activin signaling inhibitor, restoring balance between the BMPR2 and TGF-beta pathways to reverse vascular remodeling.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes soluble guanylate cyclase stimulators like riociguat.\">C. It directly stimulates soluble guanylate cyclase independently of nitric oxide.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes endothelin receptor antagonists like bosentan or macitentan.\">D. It acts as a dual endothelin receptor antagonist.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q20 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q20<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In a patient with non-ischemic dilated cardiomyopathy presenting with recurrent, highly symptomatic, monomorphic bundle branch reentrant ventricular tachycardia (BBR-VT), what is the definitive curative electrophysiological intervention?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"AV node ablation treats supraventricular tachycardias with rapid ventricular response, not ventricular tachycardia.\">A. Complete ablation of the atrioventricular (AV) node<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Epicardial ablation is often needed for structural VT, but BBR-VT utilizes the specific endocardial His-Purkinje system.\">B. Epicardial ablation of the left ventricular free wall<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Bundle branch reentrant VT utilizes the macro-reentrant circuit of the His-Purkinje system. Radiofrequency ablation of the right bundle branch definitively breaks the circuit and cures the tachycardia.\">C. Radiofrequency ablation of the right bundle branch<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Left atrial appendage isolation is utilized in complex atrial fibrillation ablations.\">D. Isolation of the left atrial appendage<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q21 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q21<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Five days after an acute inferior ST-elevation myocardial infarction, a patient abruptly develops cardiogenic shock and a loud, new holosystolic murmur. Echocardiography confirms acute severe mitral regurgitation. Which anatomical structure is most likely ruptured, and what is its primary blood supply?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The anterolateral papillary muscle rarely ruptures because it has a dual blood supply from both the LAD and LCx arteries.\">A. Anterolateral papillary muscle, supplied by the left anterior descending artery<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The posteromedial papillary muscle is highly susceptible to ischemic rupture because it relies on a single blood supply, usually the posterior descending artery (PDA) from the right coronary artery, making inferior MIs high risk for this complication.\">B. Posteromedial papillary muscle, supplied by the posterior descending artery (PDA)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"VSDs present with a harsh holosystolic murmur, but the LAD supplies the anterior septum, not the typical target of inferior MIs.\">C. Muscular interventricular septum, supplied by the left circumflex artery<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Free wall rupture causes acute cardiac tamponade and pulseless electrical activity (PEA), not a loud holosystolic murmur.\">D. Left ventricular free wall, supplied by the obtuse marginal artery<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q22 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q22<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          What is the primary clinical advantage of utilizing CT-derived fractional flow reserve (CT-FFR) compared to standard coronary computed tomography angiography (CCTA)?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"CT-FFR utilizes existing CCTA image data; it does not replace the iodinated contrast requirement.\">A. It completely eliminates the need for iodinated intravenous contrast.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"CT-FFR applies computational fluid dynamics to standard CCTA images to calculate lesion-specific ischemia (functional assessment), significantly reducing the rate of unnecessary invasive angiograms for lesions that are anatomically moderate but physiologically insignificant.\">B. It provides a non-invasive functional assessment of lesion-specific ischemia using computational fluid dynamics, reducing unnecessary invasive angiograms.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"CT-FFR cannot be used to instantly dissolve calcium or deploy stents; it is a diagnostic processing tool.\">C. It allows for simultaneous non-invasive percutaneous coronary intervention via targeted ultrasound.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"CCTA does not assess valvular regurgitant fraction effectively compared to cardiac MRI or Echo.\">D. It directly measures mitral and aortic regurgitant fractions during the same scan.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q23 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q23<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Which arrhythmia syndrome is most heavily associated with the congenital presentation of Ebstein anomaly of the tricuspid valve?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Brugada syndrome is a genetic channelopathy unconnected to macroscopic tricuspid displacement.\">A. Brugada Syndrome<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Long QT Syndrome is a repolarization channelopathy.\">B. Congenital Long QT Syndrome<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Patients with Ebstein anomaly have a highly increased prevalence (up to 25%) of accessory pathways, classically presenting as Wolff-Parkinson-White (WPW) syndrome and right-sided atrioventricular reentrant tachycardias (AVRT).\">C. Wolff-Parkinson-White (WPW) Syndrome<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Idioventricular rhythm implies structural infrahisian block, not typical of Ebstein's.\">D. Accelerated idioventricular rhythm<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q24 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q24<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          According to the latest USPSTF and ACC\/AHA guidelines, what is the recommendation regarding the routine initiation of low-dose aspirin for the *primary* prevention of cardiovascular disease in adults aged 60 years or older?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Routine initiation of aspirin for primary prevention in adults &gt;= 60 is generally recommended against, as large trials (e.g., ASPREE, ARRIVE) demonstrated that the risk of major bleeding outweighs the minor ischemic benefit.\">A. It is not routinely recommended, as the risk of major bleeding outweighs the potential ischemic benefit.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Universal prescription of aspirin for all elderly individuals is an outdated practice explicitly reversed by modern guidelines.\">B. It is a Class I recommendation for all individuals over 60 regardless of risk factors.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Aspirin is not indicated to prevent heart failure; it is an antiplatelet for atherothrombosis.\">C. It should be initiated specifically to prevent new-onset heart failure.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Aspirin operates via irreversible COX-1 inhibition, not P2Y12.\">D. It is recommended only if prescribed alongside a P2Y12 inhibitor for dual antiplatelet therapy.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q25 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-blue-950 text-cyan-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-blue-500\/30\">Q25<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During transradial coronary angiography, a patient experiences severe forearm pain and the catheter becomes firmly stuck. Angiography via the sheath reveals profound diffuse narrowing of the radial artery around the catheter. What is the immediate first-line pharmacological treatment for this complication?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Protamine reverses heparin, which increases the risk of thrombosis rather than relieving smooth muscle spasm.\">A. Intravenous protamine sulfate to reverse systemic anticoagulation<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The patient is experiencing severe radial artery spasm. The definitive treatment involves administering intra-arterial vasodilators, typically a combination of verapamil\/diltiazem and nitroglycerin, directly into the radial sheath.\">B. Intra-arterial administration of vasodilators such as verapamil and nitroglycerin via the radial sheath<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Forceful pulling can result in severe arterial avulsion or endothelial stripping, causing permanent vascular injury.\">C. Forceful rapid manual traction of the catheter under fluoroscopic guidance<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Epinephrine is a potent vasoconstrictor and would drastically worsen the arterial spasm.\">D. Intravenous bolus of epinephrine to augment systemic blood pressure<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n  <\/div>\n<\/div>\n\n<script>\n  let mcq12Correct = 0;\n  let mcq12Answered = 0;\n  const mcq12Total = 25;\n\n  document.querySelectorAll('#mcq12-quiz-wrapper .quiz-card').forEach(card => {\n    const buttons = card.querySelectorAll('.opt-btn');\n    buttons.forEach(btn => {\n      btn.addEventListener('click', function() {\n        if (card.getAttribute('data-answered') === 'true') return;\n        card.setAttribute('data-answered', 'true');\n        mcq12Answered++;\n\n        document.getElementById('mcq12-answered-count').innerText = mcq12Answered;\n        const pct = (mcq12Answered \/ mcq12Total) * 100;\n        document.getElementById('mcq12-progress-bar').style.width = pct + '%';\n\n        buttons.forEach(b => {\n          b.disabled = true;\n          b.classList.remove('hover:bg-slate-900', 'cursor-pointer');\n          b.classList.add('opacity-50', 'cursor-not-allowed');\n        });\n\n        const isCorrect = this.getAttribute('data-correct') === 'true';\n        const explanation = this.getAttribute('data-explanation');\n\n        if (isCorrect) {\n          mcq12Correct++;\n          document.getElementById('mcq12-correct-count').innerText = mcq12Correct;\n          this.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n          this.classList.add('bg-emerald-950\/80', 'border-emerald-500', 'text-emerald-200', 'opacity-100', 'border-2');\n          this.innerHTML += ' <span class=\"font-bold\">&#10004; CORRECT!<\/span>';\n        } else {\n          this.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n          this.classList.add('bg-rose-950\/80', 'border-rose-500', 'text-rose-200', 'opacity-100', 'border-2');\n          this.innerHTML += ' <span class=\"font-bold\">&#10006; INCORRECT<\/span>';\n\n          buttons.forEach(b => {\n            if (b.getAttribute('data-correct') === 'true') {\n              b.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n              b.classList.add('bg-emerald-950\/40', 'border-emerald-500\/55', 'text-emerald-200', 'opacity-100', 'border-2');\n              b.innerHTML += ' <span class=\"font-bold\">&#10004; (Correct)<\/span>';\n            }\n          });\n        }\n\n        const feedback = card.querySelector('.feedback-box');\n        feedback.innerHTML = `\n          <div class=\"font-extrabold uppercase tracking-widest text-xs mb-2 ${isCorrect ? 'text-emerald-400' : 'text-rose-400'}\">\n            ${isCorrect ? 'Clinical Explanation' : 'Explanation & Correct Answer'}\n          <\/div>\n          <p class=\"m-0\">${explanation}<\/p>\n        `;\n        feedback.classList.remove('hidden');\n        feedback.classList.add('block', isCorrect ? 'bg-emerald-950\/45' : 'bg-rose-950\/20', 'border-2', 'border-solid', isCorrect ? 'border-emerald-500\/30' : 'border-rose-500\/30', 'text-slate-200', 'mt-4');\n      });\n    });\n  });\n<\/script>\n","protected":false},"excerpt":{"rendered":"<p>\u2764\ufe0f Advanced Cardiology Series &#8211; Part 12 Interactive Cardiology MCQs #12 Post-Graduate Level Clinical &#038; Hemodynamic Masterclass \ud83c\udfc6 Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 Which invasive intracoronary imaging modality provides the highest spatial resolution (10-20 micrometers) and is considered the gold standard for identifying thin-cap fibroatheromas, macrophage accumulation, and assessing stent strut endothelialization? [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":67983,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-67982","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New Series of Interactive Cardiology MCQs 12 - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Series of Interactive Cardiology MCQs 12 - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"\u2764\ufe0f Advanced Cardiology Series &#8211; Part 12 Interactive Cardiology MCQs #12 Post-Graduate Level Clinical &#038; Hemodynamic Masterclass \ud83c\udfc6 Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 Which invasive intracoronary imaging modality provides the highest spatial resolution (10-20 micrometers) and is considered the gold standard for identifying thin-cap fibroatheromas, macrophage accumulation, and assessing stent strut endothelialization? [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-24T13:21:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-24T13:21:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-12.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1208\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-12\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-12\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"New Series of Interactive Cardiology MCQs 12\",\"datePublished\":\"2026-10-24T13:21:49+00:00\",\"dateModified\":\"2026-10-24T13:21:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-12\\\/\"},\"wordCount\":1628,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-12\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-12.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-12\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-12\\\/\",\"name\":\"New Series of Interactive Cardiology MCQs 12 - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-12\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-12\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-12.jpg\",\"datePublished\":\"2026-10-24T13:21:49+00:00\",\"dateModified\":\"2026-10-24T13:21:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-12\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-12\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-12\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-12.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-12.jpg\",\"width\":1208,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-12\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Series of Interactive Cardiology MCQs 12\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Series of Interactive Cardiology MCQs 12 - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/","og_locale":"en_US","og_type":"article","og_title":"New Series of Interactive Cardiology MCQs 12 - All About Cardiovascular System and Disorders","og_description":"\u2764\ufe0f Advanced Cardiology Series &#8211; Part 12 Interactive Cardiology MCQs #12 Post-Graduate Level Clinical &#038; Hemodynamic Masterclass \ud83c\udfc6 Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 Which invasive intracoronary imaging modality provides the highest spatial resolution (10-20 micrometers) and is considered the gold standard for identifying thin-cap fibroatheromas, macrophage accumulation, and assessing stent strut endothelialization? [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-10-24T13:21:49+00:00","article_modified_time":"2026-10-24T13:21:56+00:00","og_image":[{"width":1208,"height":675,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-12.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"New Series of Interactive Cardiology MCQs 12","datePublished":"2026-10-24T13:21:49+00:00","dateModified":"2026-10-24T13:21:56+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/"},"wordCount":1628,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-12.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/","url":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/","name":"New Series of Interactive Cardiology MCQs 12 - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-12.jpg","datePublished":"2026-10-24T13:21:49+00:00","dateModified":"2026-10-24T13:21:56+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-12.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-12.jpg","width":1208,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-12\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"New Series of Interactive Cardiology MCQs 12"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67982","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=67982"}],"version-history":[{"count":1,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67982\/revisions"}],"predecessor-version":[{"id":67984,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67982\/revisions\/67984"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/67983"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=67982"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=67982"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=67982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}